PWRM, Power 3 Medical Products Inc., PWRM.OB
PWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
Alzheimer's illness (AD)-also called Alzheimer disease, senile dementia of the Alzheimer type (SDAT), primary degenerative dementia of an Alzheimer's type (PDDAT), or Alzheimer's-is the most common sort of dementia. This unique incurable, degenerative, and deadly disorder was first explained German born professional as well as neuropathologist Alois Alzheimer in 1906 and was called after him. Most often, it really is determined in individuals over 65 years of age, although the less-prevalent early-onset Alzheimer's can take place much earlier. In 2006, there have been 26.6 million patients globally. Alzheimer's is predicted to threaten 1 in 85 people today worldwide by the year 2050
Breast cancer (malignant breast neoplasm) is normally cancer originating from breast tissue, most frequently of your inside lining of milk ducts or the lobules that offer the ducts with milk. Cancers originating from ducts these are known as ductal carcinomas; people originating from lobules are known as lobular carcinomas.
Parkinson's disease is really a problem that affects nerve cells, or neurons, inside of a section of the brain of which controls muscle motions. In Parkinson's, nerves which make an important chemical called dopamine die or do not work properly. Dopamine generally delivers impulses that assist synchronize a person's activities.
PWRM has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials.
PWRM has filed several patent applications for its NuroPro® technology that are currently pending. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. PWRM intends to publish these latest findings as well.
PWRM recently reported that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.
More about PWRM at www.power3medical.com.
AMREP Corp. (NYSE:AXR) recently reported net income of $731,000, or $0.12 per share, for its fiscal 2011 second quarter ended October 31, 2010 compared to a net loss of $985,000, or $0.16 per share, for its fiscal 2010 second quarter ended October 31, 2009. For the first six months of fiscal 2011, the Company had net income of $233,000, or $0.04 per share, compared to a net loss of $2,041,000, or $0.34 per share, for the same period of fiscal 2010. Revenues were $25,816,000 and $50,903,000 for the second quarter and first six months of 2011 versus $32,333,000 and $64,790,000 for the same periods last year.
AMREP Corporation, through its subsidiaries, engages in real estate and media services businesses. The company real estate business sells developed and undeveloped lots to national, regional, and local home builders, as well as to commercial and industrial property developers.
Old Republic International Corp. (NYSE:ORI) recently declared a quarterly cash dividend on the common stock of 17.25 cents per share. This dividend is payable December 15, 2010, to shareholders of record on December 6, 2010. 2010 marks the 69th year of uninterrupted cash dividend payments, and the 29th consecutive year that Old Republic has boosted its annualized cash dividend rate. Chicago-based Old Republic International Corporation is an insurance holding company whose subsidiaries market, underwrite and provide risk management services for a wide variety of coverage, principally in the property and liability, mortgage guaranty and title insurance fields.
Old Republic International Corporation, through its subsidiaries, engages in insurance underwriting business. It operates in three segments: General Insurance, Mortgage Guaranty, and Title Insurance. The General Insurance segment provides liability insurance coverage to businesses, forest products, energy, general manufacturing, and financial services sectors in North America.
Whitestone REIT (AMEX:WSR) recently reported the appointment of Bradford D. Johnson as Director of Acquisitions and Dispositions. Mr. Johnson has over 25 years of commercial real estate experience and has previously held executive and management positions with other REITs and real estate development companies. Most recently, he served as Vice President of Acquisitions and Development with Campus Living Villages Funds Management REIT in Houston. His background includes extensive experience in real estate financial analysis related to acquisitions, redevelopment and dispositions.
Whitestone REIT, a real estate investment trust (REIT), engages in the investment and operation of retail, office, and warehouse properties located in the Houston, Dallas, San Antonio, and Phoenix metropolitan areas. As of March 31, 2008, it owned and operated 37 properties.
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).